REXULTI® (brexpiprazole) agitation that may happen with dementia due to Alzheimer's disease

Discover the only FDA-Approved treatment for agitation that may happen with dementia due to Alzheimer’s disease. See Important Safety Info and Full Prescribing Info, including Boxed WARNING.

Otsuka and Lundbeck Announce U.S. Food and Drug Administration (FDA) Approval of Supplemental New Drug Application (sNDA) for REXULTI® ( brexpiprazole) for the Treatment of Agitation Associated with Dementia Due to Alzheimer's Disease

Lundbeck, Otsuka's Rexulti wins FDA nod for Alzheimer's agitation

Lundbeck: Alzheimer's agitation drug can make a real difference — MedWatch

Managing agitation associated with dementia due to Alzheimer's disease - STAT

Psychiatry Alzheimer's Diseasearticles page [1]

FDA Approves First Drug for Alzheimer's-Related Agitation Symptoms

FAQ for agitation that may happen with dementia due to Alzheimer's disease

JAMA Neurology Publishes Complete Results of Positive Phase 3 Study of REXULTI® (brexpiprazole) for Agitation Associated with Dementia Due to Alzheimer's Disease

Psych News Alert: FDA Approves Rexulti for Agitation Associated With Dementia Due to Alzheimer's Disease